Medicine and Dentistry
Neoplasm
100%
Uterine Cancer
91%
Diseases
58%
Recurrent Disease
48%
Krukenberg Tumor
46%
Ovarian Cancer
39%
Pelvis
25%
Metastatic Carcinoma
23%
Endometrium Carcinoma
21%
Retroperitoneal Lymph Node Dissection
21%
Lymph Node
21%
Malignant Neoplasm
20%
Overall Survival
16%
Protein P53
16%
Breast Cancer
15%
Adenocarcinoma
15%
Ovarian Tumor
15%
Adjuvant Therapy
15%
Immunohistochemistry
14%
Progression Free Survival
14%
Cancer
13%
Hazard Ratio
12%
Prognostic Factor
12%
Sentinel Lymph Node
11%
Hysterectomy
11%
Fluorescence in Situ Hybridization
10%
Morphology
10%
Lymph Duct
10%
Clear Cell
9%
Ploidy
9%
Lymph Node Metastasis
9%
Endometrium
8%
Radiation Therapy
8%
Cervix
8%
Paraaortic Lymph Node
8%
Proportional Hazards Model
7%
Biological Marker
7%
Minimal Residual Disease
7%
Prevalence
7%
Cancer Staging
7%
Angioleiomyoma
7%
Adjuvant Radiotherapy
7%
Receptor Expression
6%
Serous Carcinoma
6%
Disease Specific Survival
6%
Melanoma
6%
Progesterone Receptor
6%
Disease Free Survival
6%
Reoperation
6%
Cytotechnology
6%
Keyphrases
Endometrial Cancer
75%
Tumor
67%
Ovarian Cancer
32%
Epithelial Ovarian Cancer
20%
Endometrioid
16%
Histological Subtypes
16%
Ovarian Tumor
15%
Endometrial Carcinoma
15%
Adjuvant Therapy
14%
Mayo Clinic
14%
Frozen Section
13%
Epithelial Ovarian Carcinoma
13%
Overall Survival
13%
High-grade Serous Ovarian Cancer (HGSOC)
13%
Risk Factors
12%
Lymphadenectomy
12%
Human Epidermal Growth Factor Receptor 2 (HER2)
12%
Progression-free Survival
12%
Confidence Interval
11%
Hazard Ratio
11%
Prognostic Factors
10%
Hysterectomy
10%
Metastasis
10%
Cervical Carcinoma
10%
Uterine Serous Carcinoma
10%
Chemotherapy
9%
Tumor Tissue
9%
Ovarian Carcinoma
9%
Non-endometrioid
9%
High Risk
9%
Overexpression
9%
Female Genital Tract
9%
Breast
9%
Fluorescence in Situ Hybridization
9%
Histologic
8%
Disease-specific Survival
8%
Lymph Node
8%
Tissue Analysis
8%
Folate Receptor
8%
Breast Cancer
7%
Histology
7%
Cancer Patients
7%
Stage IIIC
7%
Pelvic Lymph Nodes
7%
Lymphovascular Invasion
7%
Corpus Cancer
7%
Endometrioid Endometrial Cancer
7%
Sentinel Lymph Node
7%
Breast Reconstruction
7%
P53 Expression
7%